Colorectal carcinoma (CRC) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-BLM-CARRIER-SURVEILLANCE |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-20 | pending_clinical_signoff |
| Diseases | DIS-CRC |
| Sources | SRC-CLEARY-BLM-2003 SRC-NCCN-COLON-2025 SRC-NCCN-GENETIC-FAMILIAL-CRC-2025 |
Notes
STUB pending two-Co-Lead signoff per CHARTER §6.1 dev-mode. v0.3 wave-N niche moderate-penetrance pathway (BLM heterozygote). Sibling — IND-BLM-CARRIER-OBSERVATION (alternative plan_track).
Used By
Indication
IND-BLM-CARRIER-OBSERVATION- IND-BLM-CARRIER-OBSERVATION
Red flag
RF-BLM-CONFIRMED-CARRIER- Confirmed germline pathogenic / likely-pathogenic variant in the BLM gene — Bloom syndrom...